A prodrug approach to the design of cRaf1 kinase inhibitors with improved cellular activity.
暂无分享,去创建一个
S. Frye | R. Hunter | R. Crosby | M. Peel | J. Ray | S. Dickerson | K. Lackey | O. McDonald | R. Mcnutt | D. Jung | W. B. Mahony | E. Wood | R. Griffin